Article Details
Retrieved on: 2022-12-10 23:41:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Tifcemalimab is the world's first-in-human anti-tumor anti-BTLA monoclonal antibody independently developed by the company.
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here